is semaglutide patented Novo Nordisk and D Young defend crucial patent for tablet form of Patent expires next year: Novo

In a phase 2 randomised controlled trial published in the New England Journal of Medicine (Jastreboff et al., 2023), participants receiving the highest doses of retatrutide achieved a mean weight reduction of approximately 1724% of body weight over 48 weeks, depending on dose

C.YamadaA.KimuraS.et al

You increase your dose, nausea appears within the first week at the new dose, it peaks around days 3 to 7, then gradually fades

That changes the M&A landscape for adjacent assets across orthopedics, sleep medicine, cardiology, and diabetes

An FDA-approved medication, Zepbound has transformed thousands of lives by providing meaningful, sustainable results

They help ensure continuity of care, support treatment adherence, expand therapeutic options beyond commercially available medications, and serve niche areas like pediatrics, specialty therapies, and veterinary medicine